Challenge to patented breast cancer test
A Maltese biotechnology firm claims it has identified a loophole in the controversial patents on two genetic tests for breast cancer held by US company Myriad Genetics. Synergene says that the patents do not apply in Malta, as the country has not signed the European Patent Convention. It plans to...